Supreme Court Decision on Purdue Pharma Settlement
The Supreme Court determines that members of the Sackler family cannot be shielded from liability for civil claims related to the opioid epidemic
Eisenberg and Baum’s Michael Quinn successfully represented a respondent who opposed the Purdue Pharma settlement at the United States Supreme Court.
On June 27, 2024, the Supreme Court issued its decision in Harrington v. Purdue Pharma LP, rejecting a settlement that would have, in part, shielded the Sackler family from lawsuits despite the fact that the family made billions of dollars from selling prescription opioids.
In a 5-to-4 decision, the justices found that Purdue’s settlement deal violated bankruptcy law by including liability releases for the pharmaceutical company’s owners and operators.
If you have been affected by the opioid crisis and have questions about pursuing legal claims, call or contact us to request a free consultation.